BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

BNC210: Phase Ib data

The double-blind, double-dummy, placebo- and lorazepam-controlled, crossover, French Phase Ib BNC210.003 trial in 21 evaluable healthy male volunteers showed that single oral doses of BNC210...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >